Why Revolution Medicines (RVMD) Still Looks Like a Prime Takeover Target After Daraxonrasib Data
Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the 10 potential takeover targets with strong price momentum. The appeal…
Evaluating Valuation as Healthcare Deal Expands Its AI Platform’s Market Reach
Palantir Technologies is stepping up its healthcare ambitions through a new multi-year agreement with OneMedNet, bringing its Artificial…